Literature DB >> 8309588

Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease.

T Brousseau1, S Legrain, C Berr, V Gourlet, O Vidal, P Amouyel.   

Abstract

Family studies indicate a possible linkage between the q13.2 region of chromosome 19 and Alzheimer's disease (AD). An isoform of apolipoprotein E, whose gene maps in this region, is more frequent in AD. In this study, we investigated the possible association of a genetic polymorphism of the apolipoprotein E gene with late-onset AD. We compared apolipoprotein E polymorphism distribution between patients with sporadic late-onset AD (n = 36) and controls of the same age (n = 38). Individuals carrying at least one epsilon 4 allele were present in 41.7% of the patients, compared with only 10.5% of the controls (p < 0.001). This result indicates an association between late-onset AD and the 19q13.2 region containing the apolipoprotein E gene locus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8309588     DOI: 10.1212/wnl.44.2.342

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study.

Authors:  S Danet; T Brousseau; F Richard; P Amouyel; C Berr
Journal:  J Epidemiol Community Health       Date:  1999-07       Impact factor: 3.710

Review 2.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

Review 3.  Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator.

Authors:  R Katzman; D Kang; R Thomas
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

4.  Aluminum and Alzheimer's disease.

Authors:  D G Munoz
Journal:  CMAJ       Date:  1995-02-15       Impact factor: 8.262

5.  Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4.

Authors:  V S Rao; A Cupples; C M van Duijn; A Kurz; R C Green; H Chui; R Duara; S A Auerbach; L Volicer; J Wells; C van Broeckhoven; J H Growdon; J L Haines; L A Farrer
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

6.  Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.

Authors:  C R Harrington; J Louwagie; R Rossau; E Vanmechelen; R H Perry; E K Perry; J H Xuereb; M Roth; C M Wischik
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

Review 7.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  J C Soares; S Gershon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 8.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

9.  Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.

Authors:  T Lehtimäki; T Pirttilä; P D Mehta; H M Wisniewski; H Frey; T Nikkari
Journal:  Hum Genet       Date:  1995-01       Impact factor: 4.132

Review 10.  Genetic dissection of Alzheimer disease, a heterogeneous disorder.

Authors:  G D Schellenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.